Weill Cornell Medicine, Division of Endocrinology, Diabetes and Metabolism is a clinical research site located in New York, New York, United States 10065.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Weill Cornell Medicine, Division of Endocrinology, Diabetes and Metabolism has participated in 1 clinical trials.
Therapeutic areas: Obesity, Overweight.
Sponsors: Allurion Technologies.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Weill Cornell Medicine, Division of Endocrinology, Diabetes and Metabolism has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Weill Cornell Medicine, Division of Endocrinology, Diabetes and Metabolism has 1 clinical trials on record. Their work covers Obesity, Overweight.
Weill Cornell Medicine, Division of Endocrinology, Diabetes and Metabolism has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.